Answer the following multiple choice question, selecting from the answer A through to J. After thinking, reply directly with your answer. 

The last character of your response must be the letter you have chosen.

Question:

Recombinant alpha-iduronidase is used for the treatment of which disease/syndrome?

Options:

A: Sandhoff disease
B: Tay-Sachs disease
C: Mucolipidosis type IV
D: Fabry disease
E: Hunter syndrome
F: Krabbe disease
G: Niemann-Pick disease
H: Gaucher disease
I: Hurler syndrome
J: Pompe disease

Answer:
    
<think>
Okay, I'm trying to figure out which disease recombinant alpha-iduronidase is used to treat. I'm a bit rusty on my lysosomal storage disorders, but I'll try to think it through step by step.

First, I remember that alpha-iduronidase is an enzyme involved in the breakdown of certain molecules in the lysosome. Lysosomal storage disorders occur when these enzymes aren't working properly, leading to a buildup of substrates and various symptoms.

Recombinant alpha-iduronidase is a treatment that's given because the body isn't producing enough of the enzyme on its own. So the disease it treats must be one where alpha-iduronidase deficiency is the issue.

I think about the options given:

A: Sandhoff disease – I believe that's related to hexosaminidase A and B deficiency, which affects GM2 gangliosides. Not alpha-iduronidase.

B: Tay-Sachs – That's GM2 deficiency too, specifically hexosaminidase A. Not this enzyme.

C: Mucolipidosis type IV – I'm not exactly sure, but I think it's related to a different enzyme, maybe glucosylsphingolipidase or something else. Not alpha-iduronidase.

D: Fabry disease – That's caused by a deficiency of alpha-galactosidase A. Not the enzyme in question.

E: Hunter syndrome – Wait, I think Hunter syndrome is also known as MPS II (Mucopolysaccharidosis II). And the enzyme involved in MPS II is iduronidase. Oh, yes! So recombinant alpha-iduronidase would be used for Hunter syndrome.

F: Krabbe disease – That's a galactocerebrosidase deficiency, part of the glycosphingolipid metabolism. Not related.

G: Niemann-Pick disease – That's about sphingomyelinase deficiency. Not this enzyme.

H: Gaucher disease – That's glucocerebrosidase deficiency, leading to issues with glucocerebroside. Not alpha-iduronidase.

I: Hurler syndrome – Hurler is MPS I, which involves alpha-L-iduronidase. Wait, but isn't Hurler the severe form of MPS I? And the enzyme involved there is alpha-iduronidase. So would the treatment be recombinant alpha-iduronidase?

Wait, but I thought Hunter is the one treated with iduronidase. Let me clarify the two. MPS I is Hurler, and MPS II is Hunter. Both are X-linked, but MPS I is autosomal recessive. The enzymes are different: MPS I uses alpha-iduronidase, while MPS II uses iduronidase. Oh wait, no, I think I'm getting confused. Let me check.

No, wait: MPS I is caused by a deficiency of alpha-L-iduronidase, which leads to the accumulation of heparan and chondroitin sulphates. The severe form is Hurler syndrome, and the mild form is called Scheie syndrome. So recombinant alpha-iduronidase would be used for MPS I, which includes Hurler syndrome.

But wait, the options include both Hurler (option I) and Hunter (option E). So which one uses alpha-iduronidase?

Hunter syndrome is MPS II, which is caused by a deficiency of iduronidase, which I think is a different enzyme. So recombinant alpha-iduronidase would treat MPS I, which is Hurler syndrome.

Wait, but I'm getting a bit mixed up. Let me think again. Alpha-iduronidase is for MPS I. So Hurler is MPS I. So option I is Hurler syndrome, which would be the correct answer.

But another thought: sometimes the enzyme names can be tricky. Alpha-iduronidase is for MPS I, yes. So recombinant alpha-iduronidase is used for Hurler syndrome.

Wait, but I think I'm mixing up the options. The question is asking for recombinant alpha-iduronidase. So I need to match the enzyme to the disease.

Hurler is MPS I – yes. So the answer should be I: Hurler syndrome.

Wait, but I've heard thatHunter syndrome is treated with recombinant iduronidase, which is a different enzyme. So maybe the question is about alpha-iduronidase, which is for Hurler.

So, looking back at the options, option I is Hurler syndrome, which is MPS I, treated with alpha-iduronidase. So the answer should be I.

Wait, but looking at the options again, E is Hunter syndrome. Let me make sure.

Yes, MPS I is Hurler, MPS II is Hunter. So if the enzyme is alpha-iduronidase, then it's for MPS I, which is Hurler. So the correct answer is I: Hurler syndrome.

Wait, but I'm a bit confused because I recall that some treatments are for different forms. Let me try to remember: Gaucher is glucocerebrosidase (option H), Fabry is alpha-galactosidase (D), Hurler is alpha-iduronidase (I), and Hunter is iduronidase (E). So yes, the enzyme in question is for Hurler, so the answer is I.

But wait, the question is about recombinant alpha-iduronidase. So yes, that's for Hurler. So the correct option is I.
</think>

The correct answer is **I: Hurler syndrome**. Recombinant alpha-iduronidase is used to treat Hurler syndrome, which is a lysosomal storage disorder caused by a deficiency of the alpha-L-iduronidase enzyme. This enzyme is responsible for breaking down heparan and chondroitin sulphates, and its deficiency leads to the accumulation of these molecules, causing the symptoms of Hurler syndrome. 

The other options are associated with different enzymes and diseases, such asHunter syndrome (MPS II) being treated with recombinant iduronidase, not alpha-iduronidase.

**I**